MFDS — authorised 25 May 2007
- Marketing authorisation holder: UCB INC
- Status: likely_approved
MFDS authorised Xyzal on 25 May 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 25 May 2007.
UCB INC holds the South Korean marketing authorisation.